{"name":"Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany","slug":"merck-healthcare-kgaa-darmstadt-germany-an-affiliate-of-merc","ticker":"","exchange":"","domain":"merckhealthcarekgaadarmstadtgermanyanaffiliateofmerckkgaadarmstadtgermany.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":19,"colorKey":"oncology","drugs":[{"name":"Enpatoran high dose","genericName":"Enpatoran high dose","slug":"enpatoran-high-dose","indication":"Other","status":"phase_2"},{"name":"Reference Euthyrox®","genericName":"Reference Euthyrox®","slug":"reference-euthyrox","indication":"Other","status":"phase_1"},{"name":"Evobruitnib","genericName":"Evobruitnib","slug":"evobruitnib","indication":"Other","status":"phase_1"},{"name":"Evobrutinib MUPS-C1","genericName":"Evobrutinib MUPS-C1","slug":"evobrutinib-mups-c1","indication":"Other","status":"phase_1"},{"name":"M5049 high dose","genericName":"M5049 high dose","slug":"m5049-high-dose","indication":"Other","status":"phase_2"},{"name":"M5049 low dose","genericName":"M5049 low dose","slug":"m5049-low-dose","indication":"Other","status":"phase_2"},{"name":"Test Euthyrox®","genericName":"Test Euthyrox®","slug":"test-euthyrox","indication":"Other","status":"phase_1"},{"name":"Tuvusertib [14C]Tuvusertib microtracer","genericName":"Tuvusertib [14C]Tuvusertib microtracer","slug":"tuvusertib-14c-tuvusertib-microtracer","indication":"Other","status":"phase_1"},{"name":"[14C]Berzosertib","genericName":"[14C]Berzosertib","slug":"14c-berzosertib","indication":"Other","status":"phase_1"},{"name":"[14C]enpatoran microtracer","genericName":"[14C]enpatoran microtracer","slug":"14c-enpatoran-microtracer","indication":"Other","status":"phase_1"},{"name":"Coriogonadotropin alfa","genericName":"Coriogonadotropin alfa","slug":"coriogonadotropin-alfa","indication":"Luteal phase support in assisted reproductive technology (ART) / in vitro fertilization (IVF)","status":"phase_3"},{"name":"Evobrutinib MR-T1","genericName":"Evobrutinib MR-T1","slug":"evobrutinib-mr-t1","indication":"Other","status":"phase_1"},{"name":"M2951 Low Dose","genericName":"M2951 Low Dose","slug":"m2951-low-dose","indication":"Other","status":"phase_1"},{"name":"Palcebo","genericName":"Palcebo","slug":"palcebo","indication":"Other","status":"phase_3"},{"name":"Pergoveris Liquid","genericName":"Pergoveris Liquid","slug":"pergoveris-liquid","indication":"Other","status":"phase_1"},{"name":"Reference Eutirox®","genericName":"Reference Eutirox®","slug":"reference-eutirox","indication":"Other","status":"phase_1"},{"name":"Reference Glucophage® XR","genericName":"Reference Glucophage® XR","slug":"reference-glucophage-xr","indication":"Other","status":"phase_1"},{"name":"Test Eutirox®","genericName":"Test Eutirox®","slug":"test-eutirox","indication":"Other","status":"phase_1"},{"name":"Test Glucophage® XR","genericName":"Test Glucophage® XR","slug":"test-glucophage-xr","indication":"Other","status":"phase_1"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"cardiovascular","drugs":[{"name":"Cladribine Low Dose","genericName":"Cladribine Low Dose","slug":"cladribine-low-dose","indication":"Multiple sclerosis (relapsing-remitting and progressive forms)","status":"phase_3"},{"name":"Mavenclad®","genericName":"Mavenclad®","slug":"mavenclad","indication":"Relapsing-remitting multiple sclerosis (RRMS)","status":"marketed"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Cladribine High Dose","genericName":"Cladribine High Dose","slug":"cladribine-high-dose","indication":"Hairy cell leukemia","status":"phase_3"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"neuroscience","drugs":[{"name":"Enpatoran low dose","genericName":"Enpatoran low dose","slug":"enpatoran-low-dose","indication":"Chronic kidney disease (CKD) with or without diabetes","status":"phase_2"}]}],"pipeline":[{"name":"Enpatoran high dose","genericName":"Enpatoran high dose","slug":"enpatoran-high-dose","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Reference Euthyrox®","genericName":"Reference Euthyrox®","slug":"reference-euthyrox","phase":"phase_1","mechanism":"Levothyroxine replaces deficient thyroid hormone by supplementing or replacing endogenous thyroxine (T4), which is converted to the active form triiodothyronine (T3).","indications":[],"catalyst":""},{"name":"Cladribine High Dose","genericName":"Cladribine High Dose","slug":"cladribine-high-dose","phase":"phase_3","mechanism":"Cladribine is a purine nucleoside analog that depletes lymphocytes by being incorporated into DNA and causing strand breaks, leading to selective destruction of immune cells.","indications":["Hairy cell leukemia","Chronic lymphocytic leukemia","Multiple sclerosis (relapsing-remitting)"],"catalyst":""},{"name":"Evobruitnib","genericName":"Evobruitnib","slug":"evobruitnib","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Evobrutinib MUPS-C1","genericName":"Evobrutinib MUPS-C1","slug":"evobrutinib-mups-c1","phase":"phase_1","mechanism":"Evobrutinib inhibits Bruton's tyrosine kinase (BTK), blocking B-cell activation and inflammatory signaling pathways.","indications":[],"catalyst":""},{"name":"M5049 high dose","genericName":"M5049 high dose","slug":"m5049-high-dose","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"M5049 low dose","genericName":"M5049 low dose","slug":"m5049-low-dose","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Test Euthyrox®","genericName":"Test Euthyrox®","slug":"test-euthyrox","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Tuvusertib [14C]Tuvusertib microtracer","genericName":"Tuvusertib [14C]Tuvusertib microtracer","slug":"tuvusertib-14c-tuvusertib-microtracer","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"[14C]Berzosertib","genericName":"[14C]Berzosertib","slug":"14c-berzosertib","phase":"phase_1","mechanism":"Berzosertib inhibits ataxia telangiectasia and Rad3-related (ATR) kinase, a key regulator of DNA damage response and cell cycle checkpoints.","indications":[],"catalyst":""},{"name":"[14C]enpatoran microtracer","genericName":"[14C]enpatoran microtracer","slug":"14c-enpatoran-microtracer","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Cladribine Low Dose","genericName":"Cladribine Low Dose","slug":"cladribine-low-dose","phase":"phase_3","mechanism":"Cladribine is a purine nucleoside analog that depletes lymphocytes by inhibiting ribonucleotide reductase and inducing apoptosis in dividing cells.","indications":["Multiple sclerosis (relapsing-remitting and progressive forms)","Lymphoproliferative disorders"],"catalyst":""},{"name":"Coriogonadotropin alfa","genericName":"Coriogonadotropin alfa","slug":"coriogonadotropin-alfa","phase":"phase_3","mechanism":"Coriogonadotropin alfa is a recombinant human chorionic gonadotropin (hCG) analog that stimulates the corpus luteum to produce progesterone for luteal phase support in assisted reproductive technology.","indications":["Luteal phase support in assisted reproductive technology (ART) / in vitro fertilization (IVF)"],"catalyst":""},{"name":"Enpatoran low dose","genericName":"Enpatoran low dose","slug":"enpatoran-low-dose","phase":"phase_2","mechanism":"Enpatoran low dose is a small molecule that acts as a selective and potent inhibitor of the sodium-glucose cotransporter 2 (SGLT2).","indications":["Chronic kidney disease (CKD) with or without diabetes","Heart failure"],"catalyst":""},{"name":"Evobrutinib MR-T1","genericName":"Evobrutinib MR-T1","slug":"evobrutinib-mr-t1","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"M2951 Low Dose","genericName":"M2951 Low Dose","slug":"m2951-low-dose","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Mavenclad®","genericName":"Mavenclad®","slug":"mavenclad","phase":"marketed","mechanism":"Mavenclad (cladribine) is a purine nucleoside analog that depletes lymphocytes by interfering with DNA synthesis and repair in dividing cells.","indications":["Relapsing-remitting multiple sclerosis (RRMS)","Active secondary progressive multiple sclerosis (SPMS)"],"catalyst":""},{"name":"Palcebo","genericName":"Palcebo","slug":"palcebo","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Pergoveris Liquid","genericName":"Pergoveris Liquid","slug":"pergoveris-liquid","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Reference Eutirox®","genericName":"Reference Eutirox®","slug":"reference-eutirox","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Reference Glucophage® XR","genericName":"Reference Glucophage® XR","slug":"reference-glucophage-xr","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Test Eutirox®","genericName":"Test Eutirox®","slug":"test-eutirox","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Test Glucophage® XR","genericName":"Test Glucophage® XR","slug":"test-glucophage-xr","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":23,"phaseCounts":{"phase_2":4,"phase_1":14,"phase_3":4,"marketed":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}